Clinical Trial

Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection

Study acronym: AHEAD
Recruiting
View on ClinicalTrials.gov →
Summary
The study is a multicenter, three-arm, open-label, randomized, parallel-controlled trial, which plans to enroll 306 participants diagnosed with acute type A aortic dissection (ATAAD) from 7 hospitals in China. All patients receive total arch replacement (TAR) combined with frozen elephant trunk (FET) implantation and are randomized to Group 1 (arch-clamping technique under mild hypothermia), Group 2 (arch-clamping technique under moderate hypothermia) and Group 3 (Sun's procedure using bilateral antegrade cerebral perfusion) in the ratio of 1:1:1. After a 1-year follow-up, the validity and safety of the mild hypothermic arch-clamping technique for ATAAD was evaluated via the incidence of major adverse events including death, renal replacement therapy, stroke, and paraplegia, as well as times of circulatory arrest, cardiopulmonary bypass, and mechanical ventilation, and length of ICU stay.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-25; most recent amendment 2026-04-02.
Trial Details
NCT Number NCT07150559
Lead Sponsor Beijing Anzhen Hospital
Collaborators: Yan'an Affiliated Hospital of Kunming Medical University, Xiangya Hospital of Central South University, West China Hospital, Guangzhou First People's Hospital, First Affiliated Hospital Xi'an Jiaotong University, Xijing Hospital,FMMU
Conditions Acute Type A Aortic Dissection, Hypothermia, Total Aortic Arch Replacement, Frozen Elephant Trunk, Bilateral Antegrade Cerebral Perfusion
Enrollment 306 participants
Start Date 2026-02-03
Primary Completion 2027-12-30 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-04-06